Pharmaceuticals
Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Libert (R) Long Stent
Published in Health Business Week, July 31st, 2009
Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(NASDAQ:TSX:)(NASDAQ:ANP) announced that its corporate partner, Boston Scientific Corporation (NYSE:BSX) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Libert (R) Long Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) designed for long lesions. At 38 mm, it is the longest available DES, providing doctors an option that can potentially reduce the number of stents used in more complex cases, simplifying procedures and reducing costs. It affords a more efficient treatment option for the estimated 8 to 10 percent(1) of patients with long lesions. Boston Scientific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-07-31)
More Articles from Health Business Week
- 911 Enable
E911 Support Now Available for Avaya SIP Phones - A.D.A.M., Inc.
CallMD Selects A.D.A.M. Multimedia Encyclopedia for Its Innovative Physician Service - Aaron Klein for WorldNetDaily.com
'Terrorist Leader' Fuming Mad Over 'Bruno' Movie - AARP Illinois
Older Illinoisans Struggling In Recession May Be Missing Out On Help Paying for Food - Abbott
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 - Abdominal Aortic Aneurysm
Society for Vascular Nursing Releases Patient Care Guideline: Published in June Issue of Journal of Vascular Nursing - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
